A randomized controlled trial (RCT) is a research design in which people are assigned by chance to different groups that receive different interventions or no intervention. As an experimental method, the RCT aims to make groups comparable so that differences in outcomes can be attributed with greater confidence to the interventions being tested rather than to preexisting differences between participants.

Core features

  • Randomization: allocation of participants by chance to treatment or control groups to prevent systematic differences.
  • Control group: a comparison group that may receive an alternative treatment, standard care, or a placebo.
  • Blinding: concealing group assignments from participants, caregivers, or outcome assessors; often described as single-, double- or blinded trials.
  • Outcome measurement: predefined, objective or validated measures to assess effects on health, symptoms, function, or other endpoints such as symptoms.

Development and historical context

The RCT evolved from earlier comparative studies and formalized methods for reducing bias. Over time, standards such as allocation concealment, intention-to-treat analysis and transparent reporting have become widely accepted to improve reliability. RCT methods are described and guided in clinical research regulations and methodological texts.

Common uses and examples

RCTs are widely used to evaluate medical treatments, including new drugs, surgical procedures, behavioural interventions, and public health measures. They are also applied in education and social sciences when feasible. Well-conducted RCTs contribute to clinical guidelines and policy decisions by providing higher-level evidence of causal effects than many observational designs.

Strengths, limitations and ethics

  • Strengths: when well designed, RCTs reduce selection bias and confounding, supporting causal inference.
  • Limitations: they can be costly, time-consuming, sometimes limited in generalizability, and may face practical or ethical constraints.
  • Ethics: informed consent, risk–benefit assessment, and oversight by review boards are central to responsible RCT conduct.

Finally, transparent registration, pre-specified outcomes and complete reporting are essential to interpret RCT results reliably and to minimise selective reporting and other forms of bias.

For further methodological detail and guidelines consult relevant methodological and regulatory sources or summaries at reputable research organizations: symptom assessment guidance, experimental design overviews, and specialized clinical trial resources indicated by professional bodies.

Additional practical resources and examples include trial registries, ethics guidance and methodological reviews that illustrate how RCTs are planned, executed and interpreted in contemporary research practice. See also discussions of trial phases, allocation concealment, and analysis strategies that protect validity while respecting participant safety.

Readers seeking operational details are encouraged to consult clinical trial handbooks and authoritative methodological texts linked by professional organizations: placebo considerations, blinding techniques, and regulatory guidance on evaluating interventions.